Investor Relations

Organigram is a leading Canadian licensed producer of high-quality medical and recreational cannabis.

NASDAQ (OGI) TSX (OGI)

Investor’s Presentation

View Presentation

Our Facility

Press Releases

March 23rd, 2020

Organigram Receives Health Canada License Renewal and Expansion for Final Elements of Phase 5 and Provides COVID-19 Update

March 10th, 2020

Ideal Potency of Edible Products 5MGs of THC or Less, Organigram Consumer Research Survey Concludes

March 4th, 2020

Organigram Expands Leadership Team with the Appointment of Chief Strategy Officer and Newly Appointed Chief Financial Officer

All Press Releases

Investor Events

Q1 2020 - earnings release and webcast

Call Replay | Press Release | Presentation | Transcript

Q4 and FY 2019 – earnings release and webcast

Call Replay | Press Release | Presentation | Transcript

CIBC 18th Annual Eastern Institutional Investor Conference